熱門資訊> 正文
Syra Health报告第二季度业绩
2024-08-09 22:39
- Syra Health press release (NASDAQ:SYRA): Q2 GAAP EPS of -$0.21.
- Revenue of $2M (VS. $1M in Q2/2023).
- Gross margins in 2Q24 increased 468 basis points compared to 2Q23.
- Cash balance of $1.6M and no long-term debt.
More on Syra Health Corp.
- Syra Health Corp. (SYRA) Q1 2024 Earnings Call Transcript
- Syra Health gets $5.8 million contract to train Indiana health workers
- Syra Health reports Q1 results
- Historical earnings data for Syra Health Corp.
- Financial information for Syra Health Corp.
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。